Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99974 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-24 | 2022-05-05 | 157265 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169990 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2025-07-18 | 2025-11-27 | 263166 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-07-18 | 2025-12-04 | 263169 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-05-10 | 2018-07-30 | 9912 |
| TEVA-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-22 | 2020-04-16 | 92238 |
| TEVA-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-22 | 2020-02-07 | 92241 |
| ACT ETIDROCAL | 400MG 500MG | TABLET | Actual shortage | 2018-08-01 | 2019-02-21 | 57207 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2018-12-04 | 2019-03-14 | 68592 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-02-05 | 2021-04-01 | 133470 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146089 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2022-09-22 | 2023-01-19 | 170011 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2024-09-19 | 2025-09-11 | 237984 |
| ACT FAMCICLOVIR | 125MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65497 |
| ACT FAMCICLOVIR | 500MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65500 |
| ACT FAMCICLOVIR | 250MG | TABLET | Actual shortage | 2018-10-23 | 2018-10-23 | 65502 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |